Moreover, Li et al. (2020) found that SAA1, along with TNM staging and EBV DNA levels, could serve as independent prognostic factors for NPC, underscoring its potential as a promising prognostic biomarker for the disease [39,40]. This evidence concerns the gene SAA1 and nasopharyngeal carcinoma.